Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Delayed Quote USD

Cronos Group Inc. (CRON)

1.8500
0.0000
(0.00%)
At close: May 7 at 4:00:00 PM EDT
1.8400
-0.01
(-0.54%)
After hours: May 7 at 7:59:52 PM EDT
Loading Chart for CRON
  • Previous Close 1.8500
  • Open 1.8500
  • Bid 1.8200 x 1400
  • Ask 1.8700 x 1400
  • Day's Range 1.8400 - 1.8900
  • 52 Week Range 1.6000 - 3.1400
  • Volume 1,457,335
  • Avg. Volume 1,583,672
  • Market Cap (intraday) 711.101M
  • Beta (5Y Monthly) 1.52
  • PE Ratio (TTM) 16.82
  • EPS (TTM) 0.1100
  • Earnings Date May 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 1.94

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brand names. The company is based in Stayner, Canada.

thecronosgroup.com

459

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRON

View More

Performance Overview: CRON

Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

CRON
5.13%
S&P/TSX Composite index (^GSPTSE)
2.20%

1-Year Return

CRON
29.92%
S&P/TSX Composite index (^GSPTSE)
12.88%

3-Year Return

CRON
37.50%
S&P/TSX Composite index (^GSPTSE)
21.94%

5-Year Return

CRON
66.91%
S&P/TSX Composite index (^GSPTSE)
69.62%

Compare To: CRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRON

View More

Valuation Measures

Annual
As of 5/7/2025
  • Market Cap

    711.10M

  • Enterprise Value

    -145.68M

  • Trailing P/E

    16.82

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.01

  • Price/Book (mrq)

    0.67

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    34.93%

  • Return on Assets (ttm)

    -2.94%

  • Return on Equity (ttm)

    3.63%

  • Revenue (ttm)

    117.61M

  • Net Income Avi to Common (ttm)

    41.08M

  • Diluted EPS (ttm)

    0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    858.8M

  • Total Debt/Equity (mrq)

    0.18%

  • Levered Free Cash Flow (ttm)

    -26.29M

Research Analysis: CRON

View More

Company Insights: CRON

Research Reports: CRON

View More

People Also Watch